Accosts Remedies Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
- Paid Up Capital ₹ 4.00 M
- Company Age 28 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.41 Cr
- Satisfied Charges ₹ 1.09 Cr
- Revenue Growth 0.46%
- Profit Growth 32.87%
- Ebitda -5.13%
- Net Worth 3.41%
- Total Assets -12.34%
About Accosts Remedies
Accosts Remedies Private Limited (ARPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 November 1996 and has a history of 28 years and three months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹1.41 Cr. The company has closed loans amounting to ₹1.09 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manisha Mehrotra and Akash Mehrotra serve as directors at the Company.
Company Details
-
Location
Lucknow, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232UP1996PTC021006
-
Company No.
021006
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Nov 1996
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
What products or services does Accosts Remedies Private Limited offer?
Accosts Remedies Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Anti Ulcer Drugs, Laxatives, Health Conditions, Stomach Care, Liver Care.
Who are the key members and board of directors at Accosts Remedies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manisha Mehrotra
|
Director | 10-Oct-2017 | Current |
|
Akash Mehrotra
|
Director | 25-Feb-2019 | Current |
Financial Performance of Accosts Remedies.
Accosts Remedies Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.46% increase. The company also saw a substantial improvement in profitability, with a 32.87% increase in profit. The company's net worth moved up by a moderate rise of 3.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Accosts Remedies?
In 2023, Accosts Remedies had a promoter holding of 96.13% and a public holding of 3.88%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹14.10 M
₹10.93 M
Charges Breakdown by Lending Institutions
- Others : 1.41 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Dec 2020 | Others | ₹1.41 Cr | Open |
| 28 Mar 2009 | Indian Overseas Bank | ₹9.00 M | Satisfied |
| 21 May 2004 | Indian Overseas Bank | ₹0.50 M | Satisfied |
| 27 Jan 2004 | Indian Overseas Bank | ₹0.50 M | Satisfied |
| 01 Nov 2003 | Indian Overseas Bank | ₹0.93 M | Satisfied |
How Many Employees Work at Accosts Remedies?
Unlock and access historical data on people associated with Accosts Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Accosts Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accosts Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
